Anorectal
FDA Label NDC 0363-1114

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Walgrrens for the product Anorectal (NDC 0363-1114). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient                               purpose, warningsfor external use only, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Active Ingredient                               Purpose


Lidocaine 5%......................................Local anesthetic

Warningsfor External Use Only

When using this product do not get into eyes.
Stop use and ask a doctor if • condition worsens or does
not improve within 7 days • do not exceed the
recommended daily dosage unless directed by a doctor
• in case of bleeding, consult a doctor promptly • do not put this product into the rectum by using fingers or any mechanical device or applicator

  • certan persons can develop allergic reactions to ingredients in this product. If the simptoms being treated does not subside or if redness, irritation, swelling, or other simproms develop or increase, discontinue use and consult a doctor

* Please review the disclaimer below.